{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:51:36Z","timestamp":1794009096197,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-65690-3","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T10:01:45Z","timestamp":1763028105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A large-scale human toxicogenomics resource for drug-induced liver injury prediction"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2486-1473","authenticated-orcid":false,"given":"Volker","family":"Bergen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantia","family":"Kodella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3930-0725","authenticated-orcid":false,"given":"Sreenath","family":"Srikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Barrandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Rogers-Grazado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirit","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Robichaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Lapchyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Plugis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Goddeeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2503-5545","authenticated-orcid":false,"given":"Mahdi","family":"Zamanighomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"65690_CR1","unstructured":"A New Standard. http:\/\/tools.thermofisher.com\/content\/sfs\/brochures\/D01834~.pdf."},{"key":"65690_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/rtph.2000.1399","volume":"32","author":"H Olson","year":"2000","unstructured":"Olson, H. et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol. 32, 56\u201367 (2000).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"65690_CR3","doi-asserted-by":"crossref","unstructured":"Onakpoya, I. J., Heneghan, C. J. & Aronson, J. K. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 14, 10 (2016).","DOI":"10.1186\/s12916-016-0553-2"},{"key":"65690_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00204-016-1874-9","volume":"91","author":"C Funk","year":"2017","unstructured":"Funk, C. & Roth, A. Current limitations and future opportunities for prediction of DILI from in vitro. Arch. Toxicol. 91, 131\u2013142 (2017).","journal-title":"Arch. Toxicol."},{"key":"65690_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fphar.2016.00267","volume":"7","author":"M Robles-D\u00edaz","year":"2016","unstructured":"Robles-D\u00edaz, M., Medina-Caliz, I., Stephens, C., Andrade, R. J. & Lucena, M. I. Biomarkers in DILI: One more step forward. Front. Pharmacol. 7, 267 (2016).","journal-title":"Front. Pharmacol."},{"key":"65690_CR6","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1053\/j.gastro.2010.04.001","volume":"138","author":"N Chalasani","year":"2010","unstructured":"Chalasani, N. & Bj\u00f6rnsson, E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 138, 2246\u20132259 (2010).","journal-title":"Gastroenterology"},{"key":"65690_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/cpt.564","volume":"101","author":"M Mosedale","year":"2017","unstructured":"Mosedale, M. & Watkins, P. B. Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management. Clin. Pharmacol. Ther. 101, 469\u2013480 (2017).","journal-title":"Clin. Pharmacol. Ther."},{"key":"65690_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/10937404.2023.2261848","volume":"26","author":"R Allison","year":"2023","unstructured":"Allison, R. et al. Drug induced liver injury - a 2023 update. J. Toxicol. Environ. Health B Crit. Rev. 26, 442\u2013467 (2023).","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"65690_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41573-019-0048-x","volume":"19","author":"RJ Weaver","year":"2020","unstructured":"Weaver, R. J. et al. Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models. Nat. Rev. Drug Discov. 19, 131\u2013148 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"65690_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/toxsci\/kft189","volume":"136","author":"M Chen","year":"2013","unstructured":"Chen, M. et al. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs. Toxicol. Sci. 136, 242\u2013249 (2013).","journal-title":"Toxicol. Sci."},{"key":"65690_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1638-4","volume":"18","author":"E Kim","year":"2017","unstructured":"Kim, E. & Nam, H. Prediction models for drug-induced hepatotoxicity by using weighted molecular fingerprints. BMC Bioinforma. 18, 227 (2017).","journal-title":"BMC Bioinforma."},{"key":"65690_CR12","doi-asserted-by":"publisher","first-page":"100432","DOI":"10.1016\/j.crmeth.2023.100432","volume":"3","author":"S Yang","year":"2023","unstructured":"Yang, S., Ooka, M., Margolis, R. J. & Xia, M. Liver three-dimensional cellular models for high-throughput chemical testing. Cell Rep. Methods 3, 100432 (2023).","journal-title":"Cell Rep. Methods"},{"key":"65690_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.drudis.2016.02.015","volume":"21","author":"M Chen","year":"2016","unstructured":"Chen, M. et al. DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov. Today 21, 648\u2013653 (2016).","journal-title":"Drug Discov. Today"},{"key":"65690_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/cld.388","volume":"4","author":"J Serrano","year":"2014","unstructured":"Serrano, J. LiverTox: An online information resource and a site for case report submission on drug-induced liver injury. Clin. Liver Dis. (Hoboken) 4, 22\u201325 (2014).","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"65690_CR15","doi-asserted-by":"publisher","first-page":"D921","DOI":"10.1093\/nar\/gku955","volume":"43","author":"Y Igarashi","year":"2015","unstructured":"Igarashi, Y. et al. Open TG-GATEs: a large-scale toxicogenomics database. Nucleic Acids Res 43, D921\u2013D927 (2015).","journal-title":"Nucleic Acids Res"},{"key":"65690_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00204-006-0091-3","volume":"80","author":"PJ O\u2019Brien","year":"2006","unstructured":"O\u2019Brien, P. J. et al. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch. Toxicol. 80, 580\u2013604 (2006).","journal-title":"Arch. Toxicol."},{"key":"65690_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","volume":"105","author":"JJ Xu","year":"2008","unstructured":"Xu, J. J. et al. Cellular imaging predictions of clinical drug-induced liver injury. Toxicol. Sci. 105, 97\u2013105 (2008).","journal-title":"Toxicol. Sci."},{"key":"65690_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/toxsci\/kfs083","volume":"127","author":"L Tolosa","year":"2012","unstructured":"Tolosa, L. et al. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs. Toxicol. Sci. 127, 187\u2013198 (2012).","journal-title":"Toxicol. Sci."},{"key":"65690_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.vascn.2013.08.001","volume":"68","author":"M Persson","year":"2013","unstructured":"Persson, M., L\u00f8ye, A. F., Mow, T. & Hornberg, J. J. A high content screening assay to predict human drug-induced liver injury during drug discovery. J. Pharmacol. Toxicol. Methods 68, 302\u2013313 (2013).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"65690_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.tiv.2013.10.015","volume":"28","author":"H Garside","year":"2014","unstructured":"Garside, H. et al. Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes. Toxicol. Vitr. 28, 171\u2013181 (2014).","journal-title":"Toxicol. Vitr."},{"key":"65690_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.tiv.2015.09.019","volume":"30","author":"S Schadt","year":"2015","unstructured":"Schadt, S. et al. Minimizing DILI risk in drug discovery \u2014 A screening tool for drug candidates. Toxicol. Vitr. 30, 429\u2013437 (2015).","journal-title":"Toxicol. Vitr."},{"key":"65690_CR22","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s00204-017-2002-1","volume":"91","author":"WR Proctor","year":"2017","unstructured":"Proctor, W. R. et al. Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury. Arch. Toxicol. 91, 2849\u20132863 (2017).","journal-title":"Arch. Toxicol."},{"key":"65690_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/toxsci\/kfs326","volume":"132","author":"SR Khetani","year":"2013","unstructured":"Khetani, S. R. et al. Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans. Toxicol. Sci. 132, 107\u2013117 (2013).","journal-title":"Toxicol. Sci."},{"key":"65690_CR24","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/toxsci\/KFS197","volume":"129","author":"M Porceddu","year":"2012","unstructured":"Porceddu, M. et al. Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria. Toxicol. Sci. 129, 332\u2013345 (2012).","journal-title":"Toxicol. Sci."},{"key":"65690_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/toxsci\/kft223","volume":"137","author":"F Gustafsson","year":"2014","unstructured":"Gustafsson, F., Foster, A. J., Sarda, S., Bridgland-Taylor, M. H. & Kenna, J. G. A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans. Toxicol. Sci. 137, 189\u2013211 (2014).","journal-title":"Toxicol. Sci."},{"key":"65690_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/toxsci\/kfy058","volume":"163","author":"SU Vorrink","year":"2018","unstructured":"Vorrink, S. U., Zhou, Y., Ingelman-Sundberg, M. & Lauschke, V. M. Prediction of drug-induced hepatotoxicity using long-term stable primary hepatic 3D spheroid cultures in chemically defined conditions. Toxicol. Sci. 163, 655\u2013665 (2018).","journal-title":"Toxicol. Sci."},{"key":"65690_CR27","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00204-019-02492-9","volume":"93","author":"W Albrecht","year":"2019","unstructured":"Albrecht, W. et al. Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations. Arch. Toxicol. 93, 1609\u20131637 (2019).","journal-title":"Arch. Toxicol."},{"key":"65690_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1021\/acs.chemrestox.9b00262","volume":"33","author":"MD Aleo","year":"2020","unstructured":"Aleo, M. D. et al. Moving beyond binary predictions of human drug-induced liver injury (DILI) toward contrasting relative risk potential. Chem. Res. Toxicol. 33, 223\u2013238 (2020).","journal-title":"Chem. Res. Toxicol."},{"key":"65690_CR29","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1021\/tx300075j","volume":"25","author":"MZ Sakatis","year":"2012","unstructured":"Sakatis, M. Z. et al. Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chem. Res. Toxicol. 25, 2067\u20132082 (2012).","journal-title":"Chem. Res. Toxicol."},{"key":"65690_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1124\/dmd.111.040758","volume":"40","author":"S Dawson","year":"2012","unstructured":"Dawson, S., Stahl, S., Paul, N., Barber, J. & Kenna, J. G. In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug Metab. Dispos. 40, 130\u2013138 (2012).","journal-title":"Drug Metab. Dispos."},{"key":"65690_CR31","unstructured":"Wang, E. et al. TxGemma: Efficient and Agentic LLMs for Therapeutics. arXiv [cs.AI] (2025)."},{"key":"65690_CR32","doi-asserted-by":"publisher","unstructured":"Lee, T. & Posma, J. Improving drug-induced liver injury prediction using graph neural networks with augmented graph features from molecular optimisation. ChemRxiv https:\/\/doi.org\/10.26434\/chemrxiv-2024-d12gk-v2 (2025).","DOI":"10.26434\/chemrxiv-2024-d12gk-v2"},{"key":"65690_CR33","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1021\/acs.chemrestox.4c00015","volume":"37","author":"S Seal","year":"2024","unstructured":"Seal, S. et al. Improved detection of drug-induced liver injury by integrating predicted in vivo and in vitro data. Chem. Res. Toxicol. 37, 1290\u20131305 (2024).","journal-title":"Chem. Res. Toxicol."},{"key":"65690_CR34","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1007\/s00204-020-02763-w","volume":"94","author":"PA Walker","year":"2020","unstructured":"Walker, P. A., Ryder, S., Lavado, A., Dilworth, C. & Riley, R. J. The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development. Arch. Toxicol. 94, 2559\u20132585 (2020).","journal-title":"Arch. Toxicol."},{"key":"65690_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s43856-022-00209-1","volume":"2","author":"L Ewart","year":"2022","unstructured":"Ewart, L. et al. Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology. Commun. Med. (Lond.) 2, 154 (2022).","journal-title":"Commun. Med. (Lond.)"},{"key":"65690_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/toxsci\/kfae123","volume":"203","author":"L F\u00e4s","year":"2025","unstructured":"F\u00e4s, L. et al. Physiological liver microtissue 384-well microplate system for preclinical hepatotoxicity assessment of therapeutic small molecule drugs. Toxicol. Sci. 203, 79\u201387 (2025).","journal-title":"Toxicol. Sci."},{"key":"65690_CR37","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1124\/dmd.31.8.1035","volume":"31","author":"S Wilkening","year":"2003","unstructured":"Wilkening, S., Stahl, F. & Bader, A. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab. Dispos. 31, 1035\u20131042 (2003).","journal-title":"Drug Metab. Dispos."},{"key":"65690_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.taap.2007.03.032","volume":"222","author":"KM Olsavsky","year":"2007","unstructured":"Olsavsky, K. M. et al. Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol. Appl. Pharmacol. 222, 42\u201356 (2007).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"65690_CR39","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00204-014-1400-x","volume":"88","author":"M Grinberg","year":"2014","unstructured":"Grinberg, M. et al. Toxicogenomics directory of chemically exposed human hepatocytes. Arch. Toxicol. 88, 2261\u20132287 (2014).","journal-title":"Arch. Toxicol."},{"key":"65690_CR40","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.3390\/ijms20122910","volume":"20","author":"M Kiamehr","year":"2019","unstructured":"Kiamehr, M. et al. Dedifferentiation of primary hepatocytes is accompanied with reorganization of lipid metabolism indicated by altered molecular lipid and miRNA profiles. Int. J. Mol. Sci. 20, 2910 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"65690_CR41","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2024","unstructured":"Zdrazil, B. et al. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res 52, D1180\u2013D1192 (2024).","journal-title":"Nucleic Acids Res"},{"key":"65690_CR42","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/toxsci\/kfv152","volume":"147","author":"F Shah","year":"2015","unstructured":"Shah, F. et al. Setting clinical exposure levels of concern for drug-induced liver injury (DILI) using mechanistic in vitro assays. Toxicol. Sci. 147, 500\u2013514 (2015).","journal-title":"Toxicol. Sci."},{"key":"65690_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1021\/acs.chemrestox.9b00264","volume":"33","author":"DP Williams","year":"2020","unstructured":"Williams, D. P., Lazic, S. E., Foster, A. J., Semenova, E. & Morgan, P. Predicting drug-induced liver injury with Bayesian machine learning. Chem. Res. Toxicol. 33, 239\u2013248 (2020).","journal-title":"Chem. Res. Toxicol."},{"key":"65690_CR44","doi-asserted-by":"publisher","first-page":"D1301","DOI":"10.1093\/nar\/gkr1074","volume":"40","author":"T Kelder","year":"2012","unstructured":"Kelder, T. et al. WikiPathways: building research communities on biological pathways. Nucleic Acids Res. 40, D1301\u2013D1307 (2012).","journal-title":"Nucleic Acids Res"},{"key":"65690_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"65690_CR46","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3389\/fgene.2018.00636","volume":"9","author":"MS Rao","year":"2018","unstructured":"Rao, M. S. et al. Comparison of RNA-Seq and microarray gene expression platforms for the toxicogenomic evaluation of liver from short-term rat toxicity studies. Front. Genet. 9, 636 (2018).","journal-title":"Front. Genet."},{"key":"65690_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10565-020-09537-1","volume":"37","author":"J Allard","year":"2021","unstructured":"Allard, J. et al. Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity. Cell Biol. Toxicol. 37, 151\u2013175 (2021).","journal-title":"Cell Biol. Toxicol."},{"key":"65690_CR48","unstructured":"Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. in LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (2012)."},{"key":"65690_CR49","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.3390\/ijms22136900","volume":"22","author":"A Hliwa","year":"2021","unstructured":"Hliwa, A., Ramos-Molina, B., Laski, D., Mika, A. & Sledzinski, T. The role of fatty acids in non-alcoholic fatty liver disease progression: An update. Int. J. Mol. Sci. 22, 6900 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"65690_CR50","doi-asserted-by":"crossref","unstructured":"Osborne, T. F. & Espenshade, P. J. Lipid balance must be just right to prevent development of severe liver damage. J. Clin. Investig. 132, 11 (2022).","DOI":"10.1172\/JCI160326"},{"key":"65690_CR51","doi-asserted-by":"crossref","unstructured":"Shang, H. et al. Gut microbiota-derived tryptophan metabolites alleviate liver injury via AhR\/Nrf2 activation in pyrrolizidine alkaloids-induced sinusoidal obstruction syndrome. Cell Biosci. 13, 1 (2023).","DOI":"10.1186\/s13578-023-01078-4"},{"key":"65690_CR52","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2147\/JIR.S385977","volume":"16","author":"L Zhu","year":"2023","unstructured":"Zhu, L. et al. The emerging role of ferroptosis in various chronic liver diseases: Opportunity or challenge. J. Inflamm. Res. 16, 381\u2013389 (2023).","journal-title":"J. Inflamm. Res."},{"key":"65690_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.640799","volume":"8","author":"S-S Chen","year":"2021","unstructured":"Chen, S.-S. et al. Serum metabolomic analysis of chronic drug-induced liver injury with or without cirrhosis. Front. Med. (Lausanne) 8, 640799 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"65690_CR54","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/hep.24148","volume":"53","author":"M Wagner","year":"2011","unstructured":"Wagner, M., Zollner, G. & Trauner, M. Nuclear receptors in liver disease. Hepatology 53, 1023\u20131034 (2011).","journal-title":"Hepatology"},{"key":"65690_CR55","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/jn\/nxaa032","volume":"150","author":"RP da Silva","year":"2020","unstructured":"da Silva, R. P., Eudy, B. J. & Deminice, R. One-carbon metabolism in fatty liver disease and fibrosis: One-carbon to rule them all. J. Nutr. 150, 994\u20131003 (2020).","journal-title":"J. Nutr."},{"key":"65690_CR56","doi-asserted-by":"publisher","first-page":"737","DOI":"10.21037\/atm-20-5110","volume":"9","author":"S-Y Cai","year":"2021","unstructured":"Cai, S.-Y. & Boyer, J. L. The role of bile acids in cholestatic liver injury. Ann. Transl. Med. 9, 737 (2021).","journal-title":"Ann. Transl. Med."},{"key":"65690_CR57","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1056\/NEJMc045711","volume":"351","author":"WA Ray","year":"2004","unstructured":"Ray, W. A., Griffin, M. R. & Stein, C. M. Cardiovascular toxicity of valdecoxib. N. Engl. J. Med. 351, 2767 (2004).","journal-title":"N. Engl. J. Med."},{"key":"65690_CR58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0196-0644(00)70119-3","volume":"35","author":"M Shrier","year":"2000","unstructured":"Shrier, M., D\u00edaz, J. E. & Tsarouhas, N. Cardiotoxicity associated with bupropion overdose. Ann. Emerg. Med. 35, 100 (2000).","journal-title":"Ann. Emerg. Med."},{"key":"65690_CR59","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s13181-013-0378-8","volume":"10","author":"M Levine","year":"2014","unstructured":"Levine, M., Pizon, A. F., Padilla-Jones, A. & Ruha, A.-M. Warfarin overdose: a 25-year experience. J. Med. Toxicol. 10, 156\u2013164 (2014).","journal-title":"J. Med. Toxicol."},{"key":"65690_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15932","volume":"8","author":"P Kohonen","year":"2017","unstructured":"Kohonen, P. et al. A transcriptomics data-driven gene space accurately predicts liver cytopathology and drug-induced liver injury. Nat. Commun. 8, 15932 (2017).","journal-title":"Nat. Commun."},{"key":"65690_CR61","doi-asserted-by":"publisher","unstructured":"Bergen, V., Srikrishnan, S. & Cellarity Inc. Cellarity\/DILImap. (Zenodo, 2025). https:\/\/doi.org\/10.5281\/ZENODO.17290520.","DOI":"10.5281\/ZENODO.17290520"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65690-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65690-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65690-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:04:37Z","timestamp":1769213077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65690-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65690"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65690-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors were employees of Cellarity Inc. at the time the study was performed and hold equity in the company. The research was funded by Cellarity. V.B., K.K., and O.B. are inventors on patent application WO2025\/024525, related to methods for DILI prediction, assigned to Cellarity.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9860"}}